Empagliflozin
Sub-Class: SGLT2 Inhibitors
🩺 Indications & Clinical Uses
Type 2 Diabetes, cardiovascular risk reduction, and heart failure.
⚙️ Mechanism of Action & Usage
Taken orally once daily in the morning.
⚠️ Precautions & Considerations
Assess renal function prior to therapy.
💊 International Available Strengths (USP / BP)
10mg25mg
⚠️ STRICTLY FOR B2B LICENSED TRADERS ONLY. This page contains industrial pharmaceutical data for licensed entities. It is NOT a medical prescription or treatment guide. If you are experiencing a medical emergency, call 112 / local emergency services or go to the nearest hospital immediately.
Reference only for B2B sourcing
